Decrease post-transplant relapse using donor-derived expanded NK-cells is a research paper published in Leukemia (2021). On theSindex it has a DataRank of 2.5. It has been cited 104 times, with 89 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.698
From this paper's citation signal
Citation Network Contribution
1.8
From 65 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 89 citers.
National Institutes of Health
Grant: 3P01CA049639-08S1
THERAPY OF CML
National Institutes of Health
Grant: 3P30CA016672-41S4
Cancer Center Support (CORE) Grant
NCI NIH HHS
Grant: P01 CA049639
NCI NIH HHS
Grant: P30 CA016058
NCI NIH HHS
Grant: P30 CA016672
FWCI
5.27
Citation Percentile
1.0%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison
Additional file 1 of CAR T cells outperform CAR NK cells in CAR-mediated effector functions in head-to-head comparison